| Literature DB >> 30576655 |
Kah Suan Lim1, Heng Li2, Emma A Roberts1, Emily F Gaudiano1, Connor Clairmont1, Larissa Alina Sambel3, Karthikeyan Ponnienselvan1, Jessica C Liu1, Chunyu Yang3, David Kozono1, Kalindi Parmar3, Timur Yusufzai1, Ning Zheng4, Alan D D'Andrea5.
Abstract
BRCA1-deficient tumor cells have defects in homologous-recombination repair and replication fork stability, resulting in PARP inhibitor sensitivity. Here, we demonstrate that a deubiquitinase, USP1, is upregulated in tumors with mutations in BRCA1. Knockdown or inhibition of USP1 resulted in replication fork destabilization and decreased viability of BRCA1-deficient cells, revealing a synthetic lethal relationship. USP1 binds to and is stimulated by fork DNA. A truncated form of USP1, lacking its DNA-binding region, was not stimulated by DNA and failed to localize and protect replication forks. Persistence of monoubiquitinated PCNA at the replication fork was the mechanism of cell death in the absence of USP1. Taken together, USP1 exhibits DNA-mediated activation at the replication fork, protects the fork, and promotes survival in BRCA1-deficient cells. Inhibition of USP1 may be a useful treatment for a subset of PARP-inhibitor-resistant BRCA1-deficient tumors with acquired replication fork stabilization.Entities:
Keywords: BRCA1; PCNA; UAF1; USP1; deubiquitinating enzymes; replication fork
Mesh:
Substances:
Year: 2018 PMID: 30576655 PMCID: PMC6390489 DOI: 10.1016/j.molcel.2018.10.045
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970